CellChorus is a startup based in the United States, 1 tracked investor.
Based in the United States, CellChorus is a startup. Brouky records 1 investor associated with the company.
CellChorus develops the TIMING platform, a technology that uses neural network-based microscopy to analyze thousands of single immune cells simultaneously, characterizing their migration, interactions, and functions to support cell therapy development and clinical research.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.